<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Costa TFR</submitter><funding>Isaac Newton Trust</funding><funding>National Council for Scientific and Technological Development</funding><funding>UK Research and Innovation</funding><funding>Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro</funding><pagination>656</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9820468</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>The protozoan &lt;i>Trypanosoma brucei rhodesiense&lt;/i> causes Human African Trypanosomiasis, also known as sleeping sickness, and penetrates the central nervous system, leading to meningoencephalitis. The Cathepsin L-like cysteine peptidase of &lt;i>T. b. rhodesiense&lt;/i> has been implicated in parasite penetration of the blood-brain barrier and its activity is modulated by the chagasin-family endogenous inhibitor of cysteine peptidases (ICP). To investigate the role of ICP in &lt;i>T. b. rhodesiense&lt;/i> bloodstream form, &lt;i>ICP&lt;/i>-null (Δ&lt;i>icp&lt;/i>) mutants were generated, and lines re-expressing &lt;i>ICP&lt;/i> (Δ&lt;i>icp:ICP&lt;/i>). Lysates of Δ&lt;i>icp&lt;/i> displayed increased E-64-sensitive cysteine peptidase activity and the mutant parasites traversed human brain microvascular endothelial cell (HBMEC) mo</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>&lt;i>Trypanosoma brucei rhodesiense&lt;/i> Inhibitor of Cysteine Peptidase (ICP) Is Required for Virulence in Mice and to Attenuate the Inflammatory Response.</pubmed_title><pmcid>PMC9820468</pmcid><funding_grant_id>311208/2017-7</funding_grant_id><funding_grant_id>MR/N017269/1</funding_grant_id><funding_grant_id>MR/P027989/1</funding_grant_id><funding_grant_id>E26/202.655/2019</funding_grant_id><pubmed_authors>Mottram JC</pubmed_authors><pubmed_authors>Costa TFR</pubmed_authors><pubmed_authors>Lima APCA</pubmed_authors><pubmed_authors>Goundry A</pubmed_authors><pubmed_authors>Morrot A</pubmed_authors><pubmed_authors>Grab DJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>Trypanosoma brucei rhodesiense&lt;/i> Inhibitor of Cysteine Peptidase (ICP) Is Required for Virulence in Mice and to Attenuate the Inflammatory Response.</name><description>The protozoan &lt;i>Trypanosoma brucei rhodesiense&lt;/i> causes Human African Trypanosomiasis, also known as sleeping sickness, and penetrates the central nervous system, leading to meningoencephalitis. The Cathepsin L-like cysteine peptidase of &lt;i>T. b. rhodesiense&lt;/i> has been implicated in parasite penetration of the blood-brain barrier and its activity is modulated by the chagasin-family endogenous inhibitor of cysteine peptidases (ICP). To investigate the role of ICP in &lt;i>T. b. rhodesiense&lt;/i> bloodstream form, &lt;i>ICP&lt;/i>-null (Δ&lt;i>icp&lt;/i>) mutants were generated, and lines re-expressing &lt;i>ICP&lt;/i> (Δ&lt;i>icp:ICP&lt;/i>). Lysates of Δ&lt;i>icp&lt;/i> displayed increased E-64-sensitive cysteine peptidase activity and the mutant parasites traversed human brain microvascular endothelial cell (HBMEC) mo</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-21T16:21:27.446Z</modification><creation>2025-04-21T16:21:27.446Z</creation></dates><accession>S-EPMC9820468</accession><cross_references><pubmed>36614101</pubmed><doi>10.3390/ijms24010656</doi></cross_references></HashMap>